Search results
Fluzone Quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. Fluzone Quadrivalent is approved for use in persons 6 months of age and older. 1.
- Back to Home
Sanofi offers a range of quadrivalent flu vaccines that help...
- Efficacy and safety study
Learn about the Fluzone High-Dose Quadrivalent vaccine...
- Back to Home
Sanofi offers a range of quadrivalent flu vaccines that help provide active immunization to prevent disease caused by influenza A subtype & type B viruses. Please see Important Safety Information or Prescribing Information.
Learn about the Fluzone High-Dose Quadrivalent vaccine indicated for prevention of influenza with 4X more antigen than a standard-dose influenza vaccine. Please see Important Safety Information or Prescribing Information.
Izikson R, et al. (2022) Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study.
May 30, 2023 · Fluzone High-Dose Quadrivalent contains four times the antigen, the part of the vaccine that helps your body build up protection against flu viruses, than Fluzone Quadrivalent and other standard-dose inactivated flu vaccines.
Jul 1, 2022 · In a clinical study, Flublok Quadrivalent is the first and only recombinant influenza vaccine for adults 18+ that was proven to be 30% more effective than a standard dose vaccine at preventing flu infection in over 9,000 adults 50+. 1 In adults 50+, the most common side effects were tenderness, and/or pain at the injection site; headache, and ti...
Oct 7, 2005 · Fluzone® High-Dose Quadrivalent is a high-dose quadrivalent influenza vaccine, indicated for adults aged 65 and older in North America. It is also licensed under the brand name Efluelda® in Europe where it is indicated for adults aged 60 and older.
